Inflammatory Bowel Diseases · 2023 · 19 citations · 4 references
PharmacyPharmacotherapyGastroenterologyGastrointestinal PharmacotherapyCrohn Disease PharmacotherapyGastrointestinal InflammationInflammatory Bowel DiseaseUlcerative Colitis PharmacotherapyCase Series ReviewClinical RemissionInflammatory Bowel Disease TherapyRefractory Ulcerative ColitisTreatment Refractoriness
Lay Summary We present a case series of 16 patients with ulcerative colitis who received upadacitinib after failing tofacitinib. Five patients (36%) achieved steroid-free clinical remission. Five (62%) demonstrated endoscopic response, while 2 patients (25%) achieved endoscopic remission. Adverse events were low.
4
Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 597 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +10